|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/435 |
| (11) | Number of the document | 3129395 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15713529.4 |
| Date of filing the European patent application | 2015-04-02 | |
| (97) | Date of publication of the European application | 2017-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/057416 |
| Date | 2015-04-02 |
| (87) | Number | WO 2015/155139 |
| Date | 2015-10-15 |
| (30) | Number | Date | Country code |
| 14305501 | 2014-04-07 | EP |
| (72) |
BOSSART, Martin, DE
ELVERT, Ralf, DE
EVERS, Andreas, DE
HAACK, Torsten, DE
STENGELIN, Siegfried, DE
WAGNER, Michael, DE
|
| (73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | EXENDIN-4 DERIVATIVES AS PEPTIDIC DUAL GLP-1 / GLUCAGON RECEPTOR AGONISTS |
| EXENDIN-4 DERIVATIVES AS PEPTIDIC DUAL GLP-1 / GLUCAGON RECEPTOR AGONISTS |